Skip to main content
. 2021 Nov 4;9:1382. Originally published 2020 Nov 30. [Version 2] doi: 10.12688/f1000research.27165.2

Table 3. Differential diagnosis and distinguishing features of neuroleptic malignant syndrome.

Differential diagnosis Distinguishing features
Systemic causes
Environmental Heatstroke History of exposure to heat
Endocrine Pheochromocytoma
Thyroid emergencies – thyrotoxicosis
Significantly elevated catecholamines
and metanephrines
Absence of neuroleptic medication
Infections Sepsis
Central nervous system infections, e.g.
brain abscess, meningitis, encephalitis
Prodromal of viral illness
Presence of seizures
Toxins / Pharmacologic agents
Anaesthetics agents causing malignant hyperthermia
Withdrawal from antiparkinsonian drugs, baclofen, alcohol
Substance abuse – amphetamines, hallucinogens
Serotonin syndrome
History of anaesthesia/surgery
Positive toxicology/drug screen
Presence of nausea, vomiting, diarrhea
Psychiatric/Neurological causes
Extrapyramidal side effects
Nonconvulsive status epilepticus
Midbrain structural lesions.
Absence of fever or leucocytosis
Presence of hyperkinesia
Absence of neuroleptic treatment